Teva Pharmaceutical Industries Limited Net Asset Quality Index
Teva Pharmaceutical Industries Limited net asset quality index. Teva Pharmaceutical Industries Limited (TEV) has a Net Asset Quality Index of 20.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €40.04 Billion minus total liabilities of €31.81 Billion yields net assets of €8.23 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check TEV cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Teva Pharmaceutical Industries Limited (2015–2025)
Net asset quality index of Teva Pharmaceutical Industries Limited from 2015 to 2025. This chart shows how Teva Pharmaceutical Industries Limited's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of March 2026, the index stands at 20.6%, representing net assets of €8.23 Billion against total assets of €40.04 Billion EUR. See shareholders equity of Teva Pharmaceutical Industries Limited for net asset value and shareholders' equity analysis.
Teva Pharmaceutical Industries Limited Net Asset Quality Index by Year (2015–2025)
Teva Pharmaceutical Industries Limited net asset quality index by year from 2015 to 2025. The table below presents the year-by-year Net Asset Quality Index for Teva Pharmaceutical Industries Limited from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Teva Pharmaceutical Industries Limited (TEV) market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 19.4% | €7.91 Billion | €40.75 Billion | €32.83 Billion | ▲ +4.9 pp |
| 2024 | 14.5% | €5.72 Billion | €39.33 Billion | €33.61 Billion | ▼ -4.1 pp |
| 2023 | 18.7% | €8.13 Billion | €43.48 Billion | €35.35 Billion | ▼ -1.1 pp |
| 2022 | 19.7% | €8.69 Billion | €44.01 Billion | €35.31 Billion | ▼ -3.8 pp |
| 2021 | 23.6% | €11.24 Billion | €47.67 Billion | €36.42 Billion | ▲ +1.7 pp |
| 2020 | 21.8% | €11.06 Billion | €50.64 Billion | €39.58 Billion | ▼ -4.4 pp |
| 2019 | 26.2% | €15.06 Billion | €57.47 Billion | €42.41 Billion | ▲ +0.2 pp |
| 2018 | 26.0% | €15.79 Billion | €60.68 Billion | €44.89 Billion | ▼ -0.5 pp |
| 2017 | 26.5% | €18.75 Billion | €70.61 Billion | €51.87 Billion | ▼ -11.1 pp |
| 2016 | 37.7% | €34.99 Billion | €92.89 Billion | €57.90 Billion | ▼ -17.5 pp |
| 2015 | 55.2% | €29.93 Billion | €54.23 Billion | €24.31 Billion | — |